AVR 0.61% $11.50 anteris technologies ltd

Price, page-30

  1. 13,950 Posts.
    lightbulb Created with Sketch. 131
    A near 2 month delay for a 25 patient study. Imagine the potential delay for a 500-1,000 patient pivotal study. Eek!

    Hopefully ethics approvals and what not don't need to be re-sought for the larger trial.

    C'mon Wayne!
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.